Two In Vitro Studies on Eravacycline (XERAVA®) Presented at IDWeek, Demonstrating Its Sustained and Robust Antimicrobial Activity SHANGHAI, Nov. 22, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, "Everest", or… CISION PRNewswireNovember 22, 2024
Turfan Leads the Way: Electricity Drives Development of Smart Irrigation Demonstration Zone TURFAN, China, Nov. 22, 2024 /PRNewswire/ — On November 19, State Grid… CISION PRNewswireNovember 22, 2024
Press ReleaseSungrow Strengthens Australian Market Presence with 1.7GWh of C&I Energy Storage Partnerships with Raystech and Solar Juice SYDNEY, Nov. 22, 2024 /PRNewswire/ — Sungrow, the global leading PV inverter… CISION PRNewswireNovember 22, 2024
Global Times: Neo-Chinese cuisine: How China is reimagining its food heritage BEIJING, Nov. 22, 2024 /PRNewswire/ — The concept of beauty has intrigued… CISION PRNewswireNovember 22, 2024
Turfan's Real-Time Power Response System Boosts Regional Tourism TURFAN, China, Nov. 22, 2024 /PRNewswire/ — On November 19, State Grid… CISION PRNewswireNovember 22, 2024
Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology ROCKVILLE, Md. and SUZHOU, China, Nov. 22, 2024 /PRNewswire/ — Ascentage Pharma… CISION PRNewswireNovember 22, 2024
Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology ROCKVILLE, Md. and SUZHOU, China, Nov. 22, 2024 /PRNewswire/ — Ascentage Pharma… CISION PRNewswireNovember 22, 2024
UN Foundation's 2024 "We the Peoples" Awards Ceremony Honors Global Leaders Rt. Hon. Dame Jacinda Ardern, former New Zealand Prime Minister, recognized as… CISION PRNewswireNovember 22, 2024
